Achieve Life Sciences Shares Rise Despite FDA CRL for Smoking Cessation Drug
Despite receiving a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its smoking cessation drug cytisinicline, Achieve Life Sciences saw its stock rise by approximately 10% in early Monday trading.
Tickers: $ACHV